UK's regulatory and legislative double standards in the treatment of psychedelics and drugs for assisted suicide.
The British journal of psychiatry : the journal of mental science July 17, 2026 Ruslan Zinchenko
The UK applies inconsistent drug regulation: drugs for assisted suicide would be approved with limited evidence, while psychedelics face barriers despite promising international evidence. The author argues that assisted-suicide drugs should meet the same standards as other medicines, and psychedelics should be rescheduled to allow more clinical research.